替诺福韦诱发范科尼综合征并伴有双侧股骨颈骨折 - Suppr

Suppr

超能文献

Tenofovir Induced Fanconi Syndrome Complicated by Bilateral Neck of Femur Fractures.

作者信息

Francis Anju K, Jacob Mariya, Koshy Jency Maria, Finny Philip

机构信息

Department of Endocrinology and Metabolism, Believers Church Medical College Hospital, Kerala, India.

Malla Reddy College of Pharmacy, Secunderabad, Telangana, India.

出版信息

Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):569-571. doi: 10.4103/ijem.ijem_363_21. Epub 2022 Feb 17.

DOI:10.4103/ijem.ijem_363_21

PMID:35355905

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959207/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b3/8959207/2cc1d1d43be2/IJEM-25-569-g001.jpg

相似文献

Tenofovir Induced Fanconi Syndrome Complicated by Bilateral Neck of Femur Fractures.

Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):569-571. doi: 10.4103/ijem.ijem_363_21. Epub 2022 Feb 17.

Pathologic femoral fracture due to tenofovir-induced Fanconi syndrome in patient with chronic hepatitis B: A case report.

Medicine (Baltimore). 2017 Nov;96(46):e8760. doi: 10.1097/MD.0000000000008760.

Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.

AIDS Read. 2007 Jun;17(6):322-8, C3.

Bilateral sub-trochanteric femur fragility fractures in a patient on antiretroviral therapy: a case based discussion and review of literature.

Int J Burns Trauma. 2020 Aug 15;10(4):121-126. eCollection 2020.

Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.

Osteoporos Int. 2019 Feb;30(2):519-523. doi: 10.1007/s00198-018-4679-2. Epub 2018 Aug 31.

Tenofovir-induced delayed nephro-osteo toxicity.

J R Coll Physicians Edinb. 2020 Sep;50(3):291-294. doi: 10.4997/JRCPE.2020.316.

Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):718-722. doi: 10.1089/AID.2016.0180. Epub 2017 May 12.

Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient.

Ther Adv Infect Dis. 2018 Jul 10;5(5):91-95. doi: 10.1177/2049936118785497. eCollection 2018 Sep.

[Tenofovir-associated Fanconi`s syndrome and rickets in a HIV infected girl].

Rev Chil Pediatr. 2017 Feb;88(1):148-152. doi: 10.1016/j.rchipe.2016.08.001.

Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.

AIDS Patient Care STDS. 2008 Feb;22(2):99-103. doi: 10.1089/apc.2007.0052.

本文引用的文献

Drug Saf. 2018 Sep;41(9):843-848. doi: 10.1007/s40264-018-0665-z.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.

AIDS. 2018 Apr 24;32(7):913-920. doi: 10.1097/QAD.0000000000001780.

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396.

Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients.

AIDS. 2017 Mar 13;31(5):643-652. doi: 10.1097/QAD.0000000000001372.

Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.

Clin Infect Dis. 2017 Feb 1;64(3):317-325. doi: 10.1093/cid/ciw765. Epub 2016 Nov 15.

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

J Antimicrob Chemother. 2015 Jul;70(7):2104-7. doi: 10.1093/jac/dkv063. Epub 2015 Mar 13.

Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):209-15. doi: 10.1097/QAI.0b013e318289bb7e.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

BMC Infect Dis. 2012 Feb 14;12:38. doi: 10.1186/1471-2334-12-38.

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

PLoS One. 2011 Feb 16;6(2):e17217. doi: 10.1371/journal.pone.0017217.

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):554-61. doi: 10.1097/QAI.0b013e3181adce44.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Tenofovir Induced Fanconi Syndrome Complicated by Bilateral Neck of Femur Fractures.

作者信息

Francis Anju K, Jacob Mariya, Koshy Jency Maria, Finny Philip

机构信息

Department of Endocrinology and Metabolism, Believers Church Medical College Hospital, Kerala, India.

Malla Reddy College of Pharmacy, Secunderabad, Telangana, India.

出版信息

Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):569-571. doi: 10.4103/ijem.ijem_363_21. Epub 2022 Feb 17.

DOI:10.4103/ijem.ijem_363_21

PMID:35355905

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959207/

Abstract

摘要

相似文献

Tenofovir Induced Fanconi Syndrome Complicated by Bilateral Neck of Femur Fractures.

Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):569-571. doi: 10.4103/ijem.ijem_363_21. Epub 2022 Feb 17.

Pathologic femoral fracture due to tenofovir-induced Fanconi syndrome in patient with chronic hepatitis B: A case report.

Medicine (Baltimore). 2017 Nov;96(46):e8760. doi: 10.1097/MD.0000000000008760.

Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.

AIDS Read. 2007 Jun;17(6):322-8, C3.

Bilateral sub-trochanteric femur fragility fractures in a patient on antiretroviral therapy: a case based discussion and review of literature.

Int J Burns Trauma. 2020 Aug 15;10(4):121-126. eCollection 2020.

Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.

Osteoporos Int. 2019 Feb;30(2):519-523. doi: 10.1007/s00198-018-4679-2. Epub 2018 Aug 31.

Tenofovir-induced delayed nephro-osteo toxicity.

J R Coll Physicians Edinb. 2020 Sep;50(3):291-294. doi: 10.4997/JRCPE.2020.316.

Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):718-722. doi: 10.1089/AID.2016.0180. Epub 2017 May 12.

Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient.

Ther Adv Infect Dis. 2018 Jul 10;5(5):91-95. doi: 10.1177/2049936118785497. eCollection 2018 Sep.

[Tenofovir-associated Fanconi`s syndrome and rickets in a HIV infected girl].

Rev Chil Pediatr. 2017 Feb;88(1):148-152. doi: 10.1016/j.rchipe.2016.08.001.

Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.

AIDS Patient Care STDS. 2008 Feb;22(2):99-103. doi: 10.1089/apc.2007.0052.

本文引用的文献

Drug Saf. 2018 Sep;41(9):843-848. doi: 10.1007/s40264-018-0665-z.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.

AIDS. 2018 Apr 24;32(7):913-920. doi: 10.1097/QAD.0000000000001780.

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396.

Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients.

AIDS. 2017 Mar 13;31(5):643-652. doi: 10.1097/QAD.0000000000001372.

Clin Infect Dis. 2017 Feb 1;64(3):317-325. doi: 10.1093/cid/ciw765. Epub 2016 Nov 15.

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

J Antimicrob Chemother. 2015 Jul;70(7):2104-7. doi: 10.1093/jac/dkv063. Epub 2015 Mar 13.

Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):209-15. doi: 10.1097/QAI.0b013e318289bb7e.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

BMC Infect Dis. 2012 Feb 14;12:38. doi: 10.1186/1471-2334-12-38.

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

PLoS One. 2011 Feb 16;6(2):e17217. doi: 10.1371/journal.pone.0017217.

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):554-61. doi: 10.1097/QAI.0b013e3181adce44.